CNS & Neurological Disorders - Drug Targets
Title:Commentary: (Research Highlights: “MiRNAcles” in Brain)
Volume: 12 Issue: 6
Author(s): Chiara Parisi and Cinzia Volonté
Affiliation:
Export Options
About this article
Cite this article as:
Parisi Chiara and Volonté Cinzia, Commentary: (Research Highlights: “MiRNAcles” in Brain), CNS & Neurological Disorders - Drug Targets 2013; 12 (6) . https://dx.doi.org/10.2174/18715273113126660180
DOI https://dx.doi.org/10.2174/18715273113126660180 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
17
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Older Adults with Amnestic Mild Cognitive Impairment Exhibit Exacerbated Gait Slowing under Dual-Task Challenges
Current Alzheimer Research Early Ischemic Blood Brain Barrier Damage: A Potential Indicator for Hemorrhagic Transformation Following Tissue Plasminogen Activator (tPA) Thrombolysis?
Current Neurovascular Research Editorial [Hot Topic: Recent Strategies for Potentiation and Facilitation of Antidepressant Treatment (Guest Editor: Eliyahu Dremencov)]
Current Drug Targets Progressive Supranuclear Palsy: Neuropsychopathological, Therapeutical and Bioethical Aspects
Current Alzheimer Research Human 90 kDa Heat Shock Protein Hsp90 as a Target for Cancer Therapeutics
Current Chemical Biology Rethinking Target Discovery in Polygenic Diseases
Current Topics in Medicinal Chemistry APP/PS1 Gene-Environment Noise Interaction Aggravates AD-like Neuropathology in Hippocampus <i>Via</i> Activation of the VDAC1 Positive Feedback Loop
Current Alzheimer Research Editorial
Current Drug Safety Assessing the Relationship between Health Utilities, Quality of Life, and Health Care Costs in Alzheimers Disease: The CATIE-AD Study
Current Alzheimer Research Modulation of the Endocannabinoid System by Lipid Rafts
Current Medicinal Chemistry The Role of MRI and PET/SPECT in Alzheimers Disease
Current Topics in Medicinal Chemistry Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function
Current Drug Metabolism Family B G Protein-coupled Receptors and their Ligands: From Structure to Function
Current Medicinal Chemistry AIDS-related Insulin Resistance and Lipodystrophy Syndrome
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Editorial (Thematic Issue: Molecular Targeting for Development of Novel Therapeutic Strategies in Brain Diseases: Myth or Reality?)
CNS & Neurological Disorders - Drug Targets Editorial {Hot topic: QSPR Models for Computer-Aided Drug Design in Microbiology, Parasitology, and Pharmacology (Guest Editor: Humberto Gonzalez-Diaz)]
Current Computer-Aided Drug Design The Low Molecular Weight Brain-derived Neurotrophic Factor Mimetics with Antidepressant-like Activity
Current Pharmaceutical Design Vascular Dementia: Atherosclerosis, Cognition and Alzheimers Disease
Current Alzheimer Research Immunotherapeutic Approaches in MS: Update on Pathophysiology and Emerging Agents or Strategies 2006
Endocrine, Metabolic & Immune Disorders - Drug Targets ACE Inhibition of Plant Alkaloids Targeted Approach for Selective Inhibition
Mini-Reviews in Organic Chemistry